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Ecology and Oceanography of Harmful
Algal Blooms
The U.S. Environmental Protection Agency (EPA),
as part of its Science to Achieve Results (STAR) pro-
gram, and its interagency partners, the National
Oceanographic and Atmospheric Administration
(NOAA), the National Aeronautic and Space
Administration (NASA), and the Office of Naval
Research (ONR), are seeking applications proposing
targeted research projects of up to 3 years duration
and, depending on appropriations, multidisciplinary
regional studies for 3–5 years for the Ecology and
Oceanography of Harmful Algal Blooms (ECOHAB)
program. This program supports research on algal
species whose populations may cause or result in
deleterious effects on ecosystems and human health.
Studies of the causes of such blooms, their detection,
effects, mitigation, and control in U.S. coastal waters
(including estuaries and Great Lakes) are solicited.
Harmful algal blooms (HABs) are caused by a
diverse group of organisms, including toxic and nox-
ious phytoplankton, some protists, cyanobacteria,
benthic algae, and macroalgae. While some HABs
occur naturally, others may be stimulated by human
activities. Blooms can extend over large geographic
areas, be composed of more than one harmful or toxic
species, and cause significant impacts on fisheries,
recreation, human health, and the ecology of both
marine and fresh water bodies. HABs are now a recur-
rent and serious problem in many areas of the United
States, and evidence suggests that the frequency and
distribution of HABs is also increasing globally,
impacting many countries that have commercial and
recreational activities in the coastal ocean.
HAB impacts on public health and local/regional
economies are also dramatic and increasing. In a
recent study, average annual economic losses in the
United States from HABs were approximated at
$49 million, with costs attributable to maintenance of
toxin monitoring programs; closures of shellﬁsh beds;
marine mammal stranding networks; collapse of some
ﬁsheries; mortality of ﬁsh, shellﬁsh, turtles, birds, and
mammals; disruptions in tourism; threats to public
and coastal resource health; publication of watershed,
health, and seafood advisories; and medical treatments
(Anderson et al. 2000, available at http://www.whoi.
edu/redtide/pertinentinfo/Economics_report.pdf).
Despite greater public awareness and advisories of
bloom events, human illnesses and even fatalities con-
tinue to be reported. Additionally, some toxins may
cause only a few documented illnesses but result in
serious public reaction and temporary aversion to
local seafood products and activities (e.g., $46 million
in lost revenue from; the 1997 Maryland fish
health/Pﬁesteria events; Anderson et al. 2000). These
deleterious impacts have increased public awareness
and demand for intervention to reduce or eliminate
bloom impacts on coastal resources, local economies,
and threats to public health.
Over the course of the last decade, numerous
national and agency reports have described the magni-
tude of the HAB problem and outlined research plans
to systematically address the issue. The ECOHAB
Program was initiated a decade ago as an interagency,
scientific program designed to increase the under-
standing of the fundamental processes underlying
the impacts and population dynamics of HABs
(ECOHAB 1995). Three major research themes
encompassing the priorities of issues of national
importance on the HAB phenomenon were identi-
ﬁed: 1) organisms, with a goal towards determining
the physiological, biochemical, and behavioral
features that inﬂuence bloom dynamics; 2) environ-
mental regulation, with a goal toward determining
and parameterizing the factors that govern the initia-
tion, growth, and maintenance of these blooms; and
3) food web and community interactions, with a goal
toward determining the extent to which food webs
and trophic structure affect and are affected by the
dynamics of HABs. Information in these areas, in
turn, supported a critical goal of the ECOHAB pro-
gram, the development of reliable models to forecast
bloom development, persistence, and toxicity. Since
1997, the ECOHAB Program has sponsored nearly
100 projects with topics ranging from molecular
aspects of HAB detection to large-scale, multidiscipli-
nary regional studies of bloom formation, mainte-
nance, and dissipation. Projects cover a wide spatial
spectrum along the U.S. coastline and its territories.
ECOHAB-sponsored projects also address the detec-
tion, prevention, control, and mitigation of HABs
and their impacts, as well as economic assessments of
these recurring events. Project summaries may be
viewed at http://www.whoi.edu/science/B/redtide/
nationplan/ecohabprojectsummaries.html
Although several research efforts have been com-
pleted or are underway, the understanding of the bio-
logical, physical, and chemical processes that regulate
HABs remains limited. Toxic blooms can impact vir-
tually all compartments of marine food webs, result-
ing in adverse effects on metabolism, viability,
growth, fecundity, and recruitment of marine organ-
isms. HAB-produced toxins can have immediate,
acute impacts on marine populations, including
marine mammals, birds, and several protected species.
Little is known about the effects of chronic, low-level
exposure. Dramatic shifts in ecosystem structure can
result from plankton blooms and macroalgal over-
growth in benthic systems. In this context, present
knowledge is inadequate to deﬁne the scale and com-
plexity of many HAB phenomena.
As a result, an additional focus on the early detec-
tion of bloom species, the environmental conditions
supporting blooms, and the toxins associated with
some HAB species is needed. Further, while there is
increasing emphasis on manipulating coastal waters to
prevent or control HABs in other nations, it is practi-
cally absent from U.S coastal management strategies.
Finally, there needs to be greater emphasis on ensur-
ing that coastal managers and the public are provided
the most current information available in a manner
that will maximize its usefulness in mitigating HAB
impacts. This would include use of observing systems
and models in the development of HAB forecasts.
The solicitation closing date is January 10, 2006.
Funding is contingent upon receipt of fiscal years
2006–2010 federal appropriations. It is anticipated
that a total of approximately $7–10 million will be
awarded, depending on the availability of funds. The
agency partners anticipate awarding approximately
15–20 funding agreements under this solicitation,
including two regional projects. Awards for targeted
studies are typically on the order of $150,000 per
year, total costs, for up to 3 years. Multi-investigator
and multi-institutional applications may include cor-
respondingly higher budgets and longer project peri-
ods, but may not exceed a 5-year project period.
You may submit either a paper application or
an electronic application (but not both) for this
solicitation. The necessary forms for submitting a
paper application will be found on the National
Center for Environmental Research website, http://
es.epa.gov/ncer/rfa/forms/. To apply electronically
you must use the application package available at
https://apply.grants.gov/forms_apps_idx.html (see
"Submission Instructions for Electronic Applications")
plus some additional forms from http://es.epa.gov/
ncer/rfa/forms/
Contact: Bronda Harrison, 202-343-9777, 
e-mail: harrison.bronda@epa.gov
Implications of Tropospheric Air Pollution for
Surface UV Exposures
The U.S. Environmental Protection Agency (EPA),
as part of its Science to Achieve Results (STAR) pro-
gram, is seeking applications proposing research to
better understand the effect of tropospheric pollution
(ozone and particulate matter) on surface ultraviolet
radiation levels.
Exposure to ultraviolet radiation (UV) has sig-
niﬁcant health and ecosystem impacts. Under current
conditions, one in five Americans will develop skin
cancer in their lifetime and one American dies every
hour from this devastating disease. Changes in air
quality affect UV exposures in ways that we do not
fully understand. The goal of this solicitation is to
enable research to better understand how changes in
tropospheric ozone and particulate matter will alter
surface UV exposures.
Several different U.S. government agencies
operate UV monitoring programs that employ
instrumentation falling into three distinctly different
categories: broad-band sensors of radiation intensity
within a spectral region between two speciﬁed levels,
narrow-band instruments measuring radiation in
several well-defined wavelength intervals, and spec-
tral devices providing detailed information on radia-
tion intensity as a function of wavelength. Details
about the various UV monitoring networks can be
found via the web at: http://www.arl.noaa.gov/
research/programs/uv.html
Between 1996 and 2004, EPA, in conjunction
with the National Park Service, operated a 21-site
monitoring network with a goal of characterizing
UV exposures and trends in a range of ecoregions
across the United States. This 21-site network used
Brewer Mark IV single-monochromator spectropho-
tometers, which measure UV radiation levels reach-
ing the Earth’s surface at 0.5 nm increments over the
wavelength range 286.3–363 nm, providing infor-
mation on UV-B and UV-A exposures. The data
from this network are available via the web at http://
www.epa.gov/uvnet/. A review of the data collected
by this network was recently completed and is avail-
able in draft form at http://www.geecresearch.com/
EPAUV.htm
EPA is currently working with the National
Oceanographic and Atmospheric Administration’s
(NOAA’s) Central UV Calibration Facility (CUCF)
to redeploy its Brewer instruments at six sites, some of
which are part of networks operated by NOAA and
the U.S. Department of Agriculture. The new net-
work will include a triad of Brewers at CUCF’s Table
Mountain Test Facility, where the Brewers will be
compared to NOAA’s reference spectro-radiometer.
The new network configuration is intended to help
characterize the performance of the Brewers and to
collect information relevant to quantifying the effects
of tropospheric ozone and fine particles on surface
UV levels and radiative forcing.
The solicitation closing date is January 18, 2006.
It is anticipated that a total of approximately
$600,000 will be awarded under this announcement,
depending on the availability of funds. The EPA
anticipates funding approximately two grants under
this RFA. The projected award per grant is $100,000Fellowships, Grants, & Awards
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per year total costs, for up to 3 years. Requests for
amounts in excess of a total of $300,000, including
direct and indirect costs, will not be considered. The
total project period for an application submitted
in response to this RFA may not exceed 3 years. The
EPA reserves the right to reject all applications and
make no awards under this RFA. The EPA reserves
the right to make additional awards under this RFA if
additional funding becomes available. Any additional
selections for awards will be made no later than
4 months after the original selection decisions.
You may submit either a paper application or
an electronic application (but not both) for this
announcement. Instructions for both forms of sub-
mission follow. For paper applications, forms can be
found on the NCER web site: http://es.epa.gov/ncer/
rfa/forms/. For electronic applications, use the appli-
cation package available at https://apply.grants.gov/
forms_apps_idx.html (see “Submission Instructions
for Electronic Applications”).
Contact: Bronda Harrison, 202-343-9777; 
e-mail: harrison.bronda@epa.gov
Interdisciplinary Partnerships in Environmental
Health Sciences
The mission of the National Institute of Environmental
Health Sciences (NIEHS) is to promote research that
will ultimately reduce the burden of human illness and
dysfunction from environmental causes. The research
supported by the NIEHS addresses this mission
through a diverse grants portfolio consisting of basic
in vitro and animal research, population-based studies,
and a limited number of patient-oriented studies that
focus on the understanding, detection, prevention, and
intervention of environmentally related disease and dis-
ease processes. Recent technological advances and a
growing appreciation that environmental factors con-
tribute to most complex diseases provide unprece-
dented opportunities for developing new research
paradigms that bring together interdisciplinary teams of
scientists to move basic environmental health sciences
research into clinical and public health practice.
The objective of this initiative is to foster scien-
tiﬁc collaboration between clinical and basic investi-
gators to accelerate the application of basic research
results into the clinical setting to improve human
health in those areas where environmental factors are
known or expected to inﬂuence the development or
progression of human disease. Scientific knowledge
achieved through this research program is expected
to move the field of environmental health sciences
into new directions and approaches for the identiﬁ-
cation, treatment, and prevention of environmen-
tally related diseases or disorders. Through this
initiative, the NIEHS will support both the develop-
ment of new collaborations between researchers with
basic and clinical expertise and the continued efforts
of existing collaborations. Both activities must
directly support the integration of clinical and basic
science research.
For the purpose of this solicitation, clinical
research is defined as: 1) patient-oriented clinical
research conducted with human subjects, or research
on the causes and consequences of disease in human
populations involving material of human origin
(such as tissue or specimens) and for which an inves-
tigator or colleague directly interacts with human
subjects in an outpatient or inpatient setting to clar-
ify a problem in human physiology, pathophysiol-
ogy, or disease; 2) development of new clinically
based technologies, therapeutic interventions, or
clinical trials; 3) epidemiologic and behavioral
studies in humans; such studies are appropriate in
cases where the primary focus of the study is on a
speciﬁc disease or disorder and the clinical investiga-
tor is an essential part of the planning, conduct, and
analysis of the study.
Basic science research is defined as mechanistic
research using experimental approaches and may
include use of cell lines, in vitro or in vivo models.
Basic research may include the development of new
tools to expand the capacity of clinically oriented
research.
Applications to this solicitation may be either
exploratory in nature, laying the foundation of long-
term collaborations or attaining proof of principle for
an innovative collaborative approach, or they may
be continued development of established collabora-
tions. In either instance, applications must focus on
a specific human disease or disorder where there is
evidence or a strong rationale for the involvement of
environmental factors in its etiology or phenotypic
expression and must involve research at both the basic
and clinical levels. Suggested topics and example
research projects include, but are not limited to, ﬁrst,
integration of basic mechanism-driven and clinical
patient-oriented research to gain new insights into
the role of environmental factors in complex human
diseases: 1) integration of patient phenotype data with
high data content techniques such as transcriptomics,
proteomics, and metabolomics to investigate the
mechanisms by which exposures lead to disease;
2) comparison of animal/model organism and human
responses to toxicants to identify biological alterations
contributing to the disease etiology; 3) examination
of the impact of current and/or prior environmental
exposures on the progression, treatment, and survival
of patients with existing disease.
Second are collaborations between basic,
patient-oriented, and epidemiologic researchers to
identify and validate biomarkers and apply them to
the development or progression of human diseases:
1) application of omics technologies and modeling
to existing populations to identify predictive marker
proﬁles for known exposures and the genesis of dis-
ease; 2) use of mechanistic response data obtained
from the conduct of basic science experimentation to
identify putative predictive markers of exposure and
response and their validation in existing cohorts;
3) coordination of engineering and clinical expertise
to develop systems that integrate exposure with indi-
vidual biological response or phenotypic change;
4) innovative approaches to the identification of
the determinants of individual susceptibility and the
interaction between genes and environmental stres-
sors in human disease.
Third is use of environmental stressors as a
probe(s) to identify phenotypic variation in humans
and animal models of disease to inform genetic
analyses of disease susceptibility: 1) conduct of
genome-wide association studies to study gene,
gene–gene and gene–environment interactions in
well characterized cases of environmentally induced
disease; 2) identiﬁcation and assessment of the func-
tional relevance of SNPs and haplotypes associated
with environmentally induced disease and the mech-
anistic consequences of those variations at the mole-
cular and cellular levels.
Fourth are interdisciplinary approaches to the
development of intervention and prevention strate-
gies to alter the progression of environmentally
induced human disease: 1) identification of novel
compounds or engineering of biocompatible materi-
als that protect against, inhibit, or reverse toxicant
actions and their validation in disease relevant
settings; 2) development of mechanistically derived
prevention strategies and application of them in
populations with known genetic susceptibility to
environmental stressors.
Fifth is collaborative development or reﬁnement
and application of model systems that faithfully repli-
cate human disease condition or species comparisons
that can be used to understand environmentally
induced human disease processes. NIEHS encourages
applicants to utilize existing biological and or other
resources to address the topics described above where
applicable, such as: 1) new analyses of data from
completed studies; 2) assay of archived biological
samples from completed and ongoing studies; 3) col-
lection of new data and samples from ongoing or
completed studies; 4) analysis of public and other
accessible databases.
Proposals addressing perturbation of biological
processes in the absence of extension to human disease
will be considered nonresponsive in the context of this
solicitation.
This funding opportunity will use the NIH
Exploratory/Developmental Grant (R21) and
Research Project Grant (R01) award mechanisms. As
an applicant, you will be solely responsible for plan-
ning, directing, and executing the proposed project.
This funding opportunity uses just-in-time
concepts. It also uses the modular as well as the non-
modular budget formats (see http://grants.nih.gov/
grants/funding/modular/modular.htm). Specifically,
if you are submitting an application with direct costs
in each year of $250,000 or less, use the modular
budget format described in the PHS 398 application
instructions. Otherwise follow the instructions for
nonmodular research grant applications.
The PHS 398 application instructions are avail-
able at http://grants.nih.gov/grants/funding/phs398/
phs398.html in an interactive format. Applicants
must use the currently approved version of the PHS
398. For further assistance, contact GrantsInfo at
301-435-0714 (telecommunications for the hearing
impaired: TTY 301-451-0088) or by e-mail:
GrantsInfo@nih.gov
Applications must be prepared using the most
current PHS 398 research grant application instruc-
tions and forms. Applications must have a D&B
Data Universal Numbering System (DUNS) number
as the universal identiﬁer when applying for Federal
grants or cooperative agreements. The D&B number
can be obtained by calling 866-705-5711 or through
the web site at http://www.dnb.com/us/. The D&B
number should be entered on line 11 of the face page
of the PHS 398 form.
The letters of intent receipt dates for this PAR
are December 11, 2005, 2006, 2007, with the appli-
cation receipt dates January 11, 2006, 2007, 2008.
The complete version of this PA is available at
http://grants/guide/pa-ﬁles/PAR-05-168
Contact: Cindy Lawler, Cellular, Organs and
Systems Pathobiology Branch, Division of Extramural
Research and Training, National Institute of
Environmental Health Sciences, P.O. Box 12233,
MD EC-23, Research Triangle Park, NC 27709
USA, 919-316-4671, fax: 919-541-5064, e-mail:
lawler@niehs.nih.gov; Kimberly Gray, Susceptibility
and Public Health Branch, Division of Extramural
Research and Training, National Institute of
Environmental Health Sciences, P.O. Box 12233,
MD EC-21, Research Triangle Park, NC 27709
USA, 919-541-0293, fax: 919- 316-4606, e-mail:
gray6@niehs.nih.gov. Reference PAR-05-168